Skip to main content
. 2020 Sep 30;12(10):937. doi: 10.3390/pharmaceutics12100937
% ID/cc percentage of injected dose per cubic centimeter of tissue
% ID/g percentage of injected dose per gram of tissue
225Ac Actinium-225
APP amyloid peptide precursor
BBB blood–brain barrier
BTB brain-tumor barrier
CDR complementary-determining region
CH1/CH2/CH3 constant domain 1/2/3 of heavy chain
CNS central nervous system
GFAP glial fibrillary acidic protein
GFP green fluorescence protein
HCAb heavy-chain antibody
HER human epidermal growth factor receptor
131I Iodine-131
ID injected dose
IGF1R insulin-like growth factor 1 receptor
IgG immunoglobulin G
111In Indium-111
NMDAR N-Methyl-D-Aspartate receptor
PDL1 program death-ligand 1
PET PET
RMT receptor-mediated transcytosis
sDAb single-domain antibody
99mTc Technetium-99m
TfR transferrin receptor
VCAM1 vascular cell adhesion molecule 1
VCAMelid VHH against VCAM1
VEGF vascular endothelium growth factor
VH variable domain of conventional antibodies heavy chain
VL variable domain of conventional antibodies light chain
VHH variable domain of heavy-chain antibodies
VHHs plural of VHH
VNAR variable new antigen receptor
WT wild-type
89Zr Zirconium 89